Updates are available Correction dated 2023-11-02
Click to view Correction: https://doi.org/10.1038/s41591-023-02663-3
-
Authors
Wilton, Daniel K.
Mastro, Kevin
Heller, Molly D.
Gergits, Frederick W.
Willing, Carly Rose
Fahey, Jaclyn B.
Frouin, Arnaud
Daggett, Anthony
Gu, Xiaofeng
Kim, Yejin A. http://orcid.org/0000-0003-1850-6678
Faull, Richard L. M.
Jayadev, Suman http://orcid.org/0000-0003-3164-9665
Yednock, Ted
Yang, X. William http://orcid.org/0000-0003-3705-7935
Stevens, Beth
-
Funding
Funding for this research was provided by:
CHDI Foundation (A-9181)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS084298, R01NS084298)
HDSA Human Biology fellowship
- License Information
-
More Information
Article History
Received: 24 November 2021
Accepted: 24 August 2023
First Online: 9 October 2023
Change Date: 2 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-023-02663-3
Competing interests
: B.S. serves on the scientific advisory board of Annexon Biosciences and is a minor shareholder of this company. T.Y. is the chief innovation officer of Annexon Biosciences, a publicly traded biotechnology company. The remaining authors declare no competing interests.
